Ascend Capital’s Chemours CC Stock Holding History

Ascend Capital’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-50,726	Closed	-$1.95M	–	159
2017 Q1	$1.95M	Buy	+50,726	New	+$1.53M	0.09%	126
2016 Q4	–	Sell	-107,125	Closed	-$1.71M	–	140
2016 Q3	$1.71M	Sell	107,125 -611,390	-85%	-$6.98M	0.1%	101
2016 Q2	$5.92M	Buy	+718,515	New	+$6.4M	0.39%	87

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ascend Capital's CC Position: Q2 2017 in Review

Ascend Capital sold out of Chemours (CC) in Q2 2017, closing a stake of 50,726 shares — an estimated $1.95M sold.

Ascend Capital first reported a position in CC in Q2 2016 and held it in 3 quarters. The position peaked at $5.92M in Q2 2016. 462 funds tracked by Wall St. Rank hold CC as of Q2 2017.

Ascend Capital reported no remaining Chemours position as of Q2 2017 after selling out during the quarter.
Ascend Capital sold 50,726 Chemours shares in Q2 2017, an estimated $1.95M.
Ascend Capital first reported a position in Chemours in Q2 2016 and held it in 3 quarters.
Ascend Capital's Chemours position peaked at $5.92M in Q2 2016.
462 funds tracked by Wall St. Rank held Chemours as of Q2 2017.

Based on Ascend Capital's 13F filing for Q2 2017, filed 11 Aug 2017.